This inventor holds 1 USPTO granted patent. Top assignee: Shox Science Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Richard A. Lerner: Innovator in Antibody Development
Introduction
Richard A. Lerner is a prominent inventor known for his significant contributions to the field of biotechnology. He has made notable advancements in the development of antibodies, particularly in relation to viral infections. His work has garnered attention for its potential impact on public health.
Latest Patents
Richard A. Lerner holds a patent for "Antibodies Against SARS-CoV-2 Spike Protein." This patent represents a crucial step in the fight against COVID-19, showcasing his commitment to addressing global health challenges. He has 1 patent to his name, reflecting his innovative approach to scientific research.
Career Highlights
Lerner has had a distinguished career, marked by his role at Shox Science Limited. His work at this company has allowed him to focus on developing cutting-edge solutions in the field of immunology. His expertise and dedication have positioned him as a leader in antibody research.
Collaborations
Throughout his career, Richard A. Lerner has collaborated with talented individuals such as Min Qiang and Hou Wang. These partnerships have enhanced his research efforts and contributed to the advancement of antibody technology.
Conclusion
In summary, Richard A. Lerner is a key figure in the development of antibodies, particularly in the context of SARS-CoV-2. His innovative work and collaborations continue to influence the field of biotechnology and public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile